contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


sectra-begins-implementation-of-its-first-digital-pathology-project-in-japan-aiming-to-improve-cancer-diagnostics-and-decrease-time-to-treatment

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Sectra operates in the medical technology industry and focuses on the development and manufacture of systems for imaging diagnostics and secure communication. The company's products are aimed at healthcare institutions and doctors. The business is conducted internationally, where the company sells through collaboration with partners all over the world. Sectra was founded in 1957 and is headquartered in Linköping.

Sorry @JNivala, for replying with such a three-year delay. I just got caught up reading about this company.  Sectra does two things: Medical IT – They develop systems that help hospitals and healthcare manage imaging + data more effectively. In practice, they help doctors do their work more efficiently and treat patients better. These are important things as the population ages and the need for care grows. Cybersecurity – Sectra also does information security stuff, especially for the defense sector, healthcare, and other critical sectors. Because everything is becoming more digital, it’s essential to protect against data breaches and cyberattacks… that’s what they do. So their solutions help keep important systems secure. In short:  Sectra earns money by selling healthcare IT solutions and cybersecurity services. The revenue stream consists of software, hardware, service agreements, and ongoing license fees – these are provided especially to hospitals, defense forces, and critical infrastructure operators who need secure and efficient systems.

@Maunotellervon_poika pystytkö / viitsitkö ihan lyhykäisyydessään vastaamaan pariin juttuun niin tietää että viitsiikö alkaa penkomaan enemmän:  Mitä osa-alueita liiketoiminnassa on? Mikä on liiketoimintamalli, mistä raha tulee? P/E Nordnetin mukaan ennustetuilla tämän vuoden luvuilla 125 ja P/S 25. Ajatuksia näistä? Johdon omistukset?

Alankomaiden puolustusministeriö jatkaa yhteistyötä Sectran kanssa:                   Investor Relations at Sectra              News and press releases | Investor Relations at Sectra    Linköping – November 30, 2021 – The Dutch Ministry of Defense has signed a new framework agreement with international cybersecurity and medical imaging IT company Sectra (https://sectra.com/) (STO: SECT B). The 5-year contract contains the...

Sectra AB on lisätty MSCI Global Small Cap - indexiin 11.11.2021 (tiedotteen sivulla 8). Samana päivänä osakkeen hinta nousi noin 9%.            app2.msci.com              MSCI_Nov21_SCPublicList.pdf    31.76 KB

Norway orders Sectra Tiger solution for sharing classified information Nov 17, 2021 | Secure Communication Systems | Norway Linköping – November 17, 2021 – The Norwegian Defence Materiel Agency has ordered additional units of the approved mobile encryption system Sectra Tiger/S from international cybersecurity and medical imaging IT company Sectra (STO: SECT B). The solution enables officials in the Norwegian defense and civil authorities to communicate securely and efficiently, preventing the risk of eavesdropping or information leakage. The new order encompasses the latest version of Sectra Tiger/S, which also guarantees the user higher availability from anywhere and at any time.                   Investor Relations at Sectra              News and press releases | Investor Relations at Sectra    Linköping – November 17, 2021 – The Norwegian Defence Materiel Agency has ordered additional units of the approved mobile encryption system Sectra Tiger/S from international cybersecurity and medical imaging IT company...

Investor Relations at Sectra              News and press releases | Investor Relations at Sectra    Linköping, Sweden and Shelton, CT – October 28, 2021 – “Brilliant workflows. Made for you.” is the key theme for international medical imaging IT and cybersecurity...

Hei, Päätin aloittaa Sectra AB:lle oman ketjun. Olen firmaa muutaman kerran kommentoinut kyberturvallisuusfoorumilla, mutta itse näen tämän profiloituvan ennen kaikkea lääketieteellisen kuvantamisen huippuosaajana ja koskapa firmalla näyttää menevän hyvin toivoisin kommentteja ja analyysejä Sectran tilasta ja tulevaisuudesta itseäni fiksummilta foorumislaisilta. Itse olen ollut itseltäni salaa Sectran kyydissä jo useita vuosia. Aluksi täysin älyttömäksi osoittatuneen Nordean Selecta vakuutusrahaston  kautta, johon säästin vuosituhannen vaihteessa ja joka myytiin minulle hiukan väkisin pankin tiskillä (silloin kun vielä asioitiin konttoreissa ). Tästä virheestä oli kuitenkin se hyöty, että tulin siten tutustuneeksi tarkemmin rahaston sisältämiin yhtiöihin ja mm. tähän Sectraan  Se kun rahaston vuosiraporteissa toistuvasti oli mukana aina vaan suuremalla ja suuremmalla osuudella ja myöhemmin sitä jopa ihan kehuttiin erikseen rahasto-esitteessä. Itsenäistä osaketta ostin ekan kerran pari-kolme vuotta sitten ja sitä on tullut tankattua muutaman kerran, viimeksi tämän kevään dipistä, mistä kurssi on jo lähes tuplaantunut. En ole katunut. Kun kurssi tämä vuonna läheni 1000 SEK niin se splitattiin äskettäin 5:1. Sectra on perustettu vuonna 1978 ja listattu Nasdac Stocholm 2014. En tiedä tarkalleen milloin rahasto otettiin Nordean Nordic Small Cap -rahastoon, jota minun on pakko omistaa eläkkeelle saakka. Viimeiset viisi vuotta kurssi ollut pääosin ylämäkeä ja tänään firman markkina-arvo oli jo 39 373,05 MSEK                    Investor Relations at Sectra              Sectra in brief | Investor Relations at Sectra    Sectra operates in the expanding niche segments of medical IT and cybersecurity. Driven by knowledge and passion, our vision is to contribute to a...                             Löysin jotain suomeksikin, tuoreehkon esityksen firmasta, missä myös Nordea Innovation Starsin Salkunhoitaja Carl Mattiassonin tuo esille näkemyksiään Sectrasta (ja yrittää myydä kyseistä rahastoa eli kriitisellä silmällä pitää tuota faktaa lukea)                   Nordea Funds              Sectra    Miten pieni, alle 800 työntekijän ruotsalaisyritys onnistuu vuosi toisensa jälkeen päihittämään oman alansa kansainväliset jätit, kuten General Electricsin ja Philipsin? Uuden Nordea Innovation Stars -rahaston sijoituskohteista kertovassa...                             Itse olen sijoittelija vähän fiilispohjalla enkä aina tutki ja kääntele kaikkia kiviä. Jospa joku teistä osaa minua tässä auttaa? Miltä vaikuttaa ja onko muilla tätä firmaa salkussa? (Omistajia Nordnetissä  1 803, lienevätkö kaikki muut ruotsalaisia vai löytyykö joku suomalainen omistaja minun lisäksi?) Lisäsin vielä tämän. Linkki tuoreimpaan videoon osavuosikatsauksesta.                   Investor Relations at Sectra              Three-month interim report 2021/2022 | Investor Relations at Sectra

Sectra

Linköping, Sweden, January 7, 2025 - International medical technology and cybersecurity company Sectra (STO: SECT B), in collaboration with distribution partner Matsunami Glass has commenced...

<div class="abstract">Linköping, Sweden, January 7, 2025 - International medical technology and cybersecurity company <a href="https://sectra.com/">Sectra</a> (STO: SECT B), in collaboration with distribution partner Matsunami Glass has commenced the implementation phase of its first digital pathology project in Japan. This milestone marks Sectra's entry into the Japanese digital pathology market and highlights the potential of its technology to advance diagnostic capabilities and support the country's evolving healthcare needs.</div>"Collaborating with Kameda Medical Center for Sectra's first digital pathology project in Japan is a significant milestone for us. We are honored to receive an order from such a respected institution and to work closely with Professor Fukuoka. This demonstrates our commitment to being a trusted partner for Japanese healthcare providers, supporting their adoption of digital pathology and enabling more efficient diagnostics to improve patient care," says Torbjörn Kronander, President and CEO of Sectra AB.The implementation of Sectra's digital pathology module at Kameda Medical Center follows a contract signed in the second quarter of Sectra's 2025/2026 fiscal year. The contract was sold by Sectra's distribution partner of digital pathology in Japan, Matsunami Glass. Sectra's digital pathology solution will allow the pathologists at Kameda Medical Center to enhance review and collaboration around cases as well as benefit from tightly integrated AI tools. The digital workflow provides instant and, when needed, remote access to digital images of tissue samples instead of relying on physical glass slides reviewed in microscopes. "After nearly a decade of successful operation as a fully digital pathology laboratory, we are entering a new phase and have made a strategic decision to transition from a scanner-restricted workflow to a comprehensive digital pathology module. To support this evolution, we are partnering with Sectra, whose platform offers robust compatibility, interoperability, and data security," says Professor Junya Fukuoka, Chair of the Department of Pathology at Kameda Medical Center.About Kameda Medical Center Recognized for its broad range of clinical services, multidisciplinary approach, and commitment to patient-centered care, Kameda Medical Center is one of Japan's largest healthcare providers. It is ranked among the top three hospitals in Japan in Newsweek's World's Best Hospitals 2025.&nbsp;The organization comprises Kameda General Hospital, Kameda Clinic, and additional clinics and rehabilitation units within the Kameda Group, altogether providing care for a large population in southern Chiba and the Tokyo metropolitan area.About Sectra's enterprise imaging solution The digital pathology module is part of Sectra's enterprise imaging solution that provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise without acquiring a new back end. Visit Sectra's website to read more about Sectra and why it's top-ranked in&nbsp;<a href="https://medical.sectra.com/about-sectra/sectra-pacs-best-in-klas/">"Best in KLAS"</a>.<div></div>